Migraine
Not recruitingStudy on Atogepant for Preventing Menstrual Migraine in Women
Study on Atogepant for Preventing Menstrual Migraine in Women
Hungary- Participants:18–64 years
- Substances:Atogepant
- Sponsor:AbbVie Deutschland GmbH & Co. KG
Rare diseases
Investigational molecules
Locations
Back to Hungary1 052 clinical trials in Budapest, Hungary across 10 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Atogepant for Preventing Menstrual Migraine in Women
HungaryStudy of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia
HungaryStudy on Avacopan with Rituximab or Cyclophosphamide for Children Aged 6 to 17 with Active ANCA-associated Vasculitis
HungaryStudy on the Effectiveness and Safety of Levetiracetam XR for Patients with Drug-Resistant Partial Onset Epilepsy
HungaryStudy on the Effectiveness and Safety of ANX007 Injections for Patients with Geographic Atrophy from Age-Related Macular Degeneration
HungaryStudy of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
HungaryStudy on the Effects of Brepocitinib and Prednisone for Adults with Active Non-Infectious Uveitis
HungaryStudy of Fuzuloparib, Abiraterone Acetate, and Prednisone for First-Line Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer
HungaryStudy on Risankizumab for Patients with Moderate to Severe Crohn's Disease
HungaryStudy of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate
HungaryLong-term safety and effectiveness study of pozelimab and cemdisiran combination treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH)
HungaryStudy on the Safety and Effectiveness of Pozelimab and Cemdisiran for Adults with Paroxysmal Nocturnal Hemoglobinuria Not Recently Treated with Complement Inhibitors
HungaryThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for inflammatory disorders, including studies on new therapies for psoriasis, psoriatic arthritis, and chronic urticaria.
Multiple clinical trials are investigating targeted therapies and their long-term effectiveness in managing inflammatory conditions.
Studies centered on preventing and treating various infections, with particular emphasis on meningococcal vaccines and respiratory conditions.
Research includes both preventive vaccines and therapeutic approaches for various infectious diseases.
Comprehensive research into heart failure prevention and management of chronic conditions, including studies on kidney disease and obesity.
Investigations focus on innovative therapeutic combinations and their impact on cardiovascular outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.